151 related articles for article (PubMed ID: 37201072)
1. Haematological and nutritional prognostic biomarkers for patients receiving CROSS or FLOT.
McNamee N; Nindra U; Shahnam A; Yoon R; Asghari R; Ng W; Karikios D; Wong M
J Gastrointest Oncol; 2023 Apr; 14(2):494-503. PubMed ID: 37201072
[TBL] [Abstract][Full Text] [Related]
2. Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers.
Shahnam A; Nindra U; McNamee N; Yoon R; Asghari R; Ng W; Karikios D; Wong M
Gastrointest Tumors; 2023; 10(1):19-28. PubMed ID: 37901653
[TBL] [Abstract][Full Text] [Related]
3. Neutrophile-to-lymphocyte, lymphocyte-to-monocyte, and platelet-to-lymphocyte ratios as prognostic and response biomarkers for resectable locally advanced gastric cancer.
Tomás TC; Eiriz I; Vitorino M; Vicente R; Gramaça J; Oliveira AG; Luz P; Baleiras M; Spencer AS; Costa LL; Liu P; Mendonça J; Dinis M; Padrão T; Correia M; Atalaia G; Silva M; Fiúza T
World J Gastrointest Oncol; 2022 Jul; 14(7):1307-1323. PubMed ID: 36051098
[TBL] [Abstract][Full Text] [Related]
4. Predictive Significance of Ki-67 and Platelet Lymphocyte Ratio in Patients with Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy.
Yilmaz H; Demirag G; Sullu Y; Yilmaz A
J Coll Physicians Surg Pak; 2021 May; 31(5):546-552. PubMed ID: 34027867
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
[No Abstract] [Full Text] [Related]
6. Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group).
Erol C; Sakin A; Başoğlu T; Özden E; Çabuk D; Doğan M; Öksüzoğlu B; Yıldırım HÇ; Öner İ; Eryılmaz MK; Dülgar Ö; Aydın D; Doğan N; Özen M; Hacıbekiroğlu İ; Özdemir N; Gürler F; Paksoy N; Karabulut S; Aksoy A; Hızal M; Kahraman S; Şen E; Paydaş S; Çılbır E; Fırat F; Akdeniz N; Özçelik M; Oyman A; Baytemür NK; Acar R; Almuradova E; Karabulut B; Şakalar T; Arak H; Değerli E; Türker S; Alan Ö; Er Ö; Taşçı EŞ; Demir N; Çavdar E; Turhal S; Dede DŞ; Akıncı MB; Yalçın B; Yumuk F; Yalçın Ş; Şendur MAN
Turk J Med Sci; 2022 Aug; 52(4):1022-1032. PubMed ID: 36326360
[TBL] [Abstract][Full Text] [Related]
7. The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study.
Yılmaz A; Mirili C; Tekin SB; Bilici M
Ir J Med Sci; 2020 Feb; 189(1):91-102. PubMed ID: 31832860
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
[TBL] [Abstract][Full Text] [Related]
9. High neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.
Ke TM; Lin LC; Huang CC; Chien YW; Ting WC; Yang CC
Medicine (Baltimore); 2020 Apr; 99(17):e19877. PubMed ID: 32332656
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
Leng J; Wu F; Zhang L
Front Oncol; 2022; 12():734948. PubMed ID: 35651788
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ
BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227
[TBL] [Abstract][Full Text] [Related]
12. The Neutrophil-Lymphocyte Ratio Is an Independent Prognostic Factor for Overall Survival in Hispanic Patients with Gastric Adenocarcinoma.
Ramos-Esquivel A; Cordero-García E; Brenes-Redondo D; Alpízar-Alpízar W
J Gastrointest Cancer; 2018 Jul; ():. PubMed ID: 30003495
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
[TBL] [Abstract][Full Text] [Related]
14. Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy.
Chen L; Zuo Y; Zhu L; Zhang Y; Li S; Ma F; Han Y; Song H; Xue Y
Onco Targets Ther; 2017; 10():2569-2580. PubMed ID: 28553122
[TBL] [Abstract][Full Text] [Related]
15. Results of the observational prospective RealFLOT study.
Giommoni E; Lavacchi D; Tirino G; Fornaro L; Iachetta F; Pozzo C; Satolli MA; Spallanzani A; Puzzoni M; Stragliotto S; Sisani M; Formica V; Giovanardi F; Strippoli A; Prisciandaro M; Di Donato S; Pompella L; Pecora I; Romagnani A; Fancelli S; Brugia M; Pillozzi S; De Vita F; Antonuzzo L
BMC Cancer; 2021 Oct; 21(1):1086. PubMed ID: 34625033
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Role of Peripheral Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy.
Ergen ŞA; Barlas C; Yıldırım C; Öksüz DÇ
J Gastrointest Cancer; 2022 Mar; 53(1):151-160. PubMed ID: 33392960
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in non-metastatic breast cancer patients from a Hispanic population.
Ramos-Esquivel A; Rodriguez-Porras L; Porras J
Breast Dis; 2017; 37(1):1-6. PubMed ID: 28035906
[TBL] [Abstract][Full Text] [Related]
18. Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor.
Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Cunningham D; Mudan S
Med Oncol; 2014 Oct; 31(10):239. PubMed ID: 25218270
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-Lymphocyte Ratio in Rectal Cancer-Novel Biomarker of Tumor Immunogenicity During Radiotherapy or Confounding Variable?
Braun LH; Baumann D; Zwirner K; Eipper E; Hauth F; Peter A; Zips D; Gani C
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108935
[TBL] [Abstract][Full Text] [Related]
20. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
